At a Glance
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support.

Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients.

Incorporated 1935
Registered Office Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai 400 013
Chairman Dr. Yusuf K. Hamied
Non-Executive Vice-Chairman Mr. M.K. Hamied
Listing Equity Shares: BSE Limited and National Stock Exchange of India Limited 
Global Depository Receipts: Luxembourg Stock Exchange
Turnover* USD 1.5 billion
Employees* 26,000
Approvals US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among others
  • Continuous innovation in R &D, over 20 world firsts.
  • Over 2,000 products, 65 therapeutic categories, over 50 dosage forms.
  • Presence in over 170 countries


Contact Mumbai Central Office: +91 22 23082891, +91 22 23095521
Peninsula Business Park Office: + 22 24826000, +91 22 24826701, +91 22 24826300
* 2012-2013